slides · global inventory
Show Traction
Slide function collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 11,828
Current window 7,981-8,010
Pages 395
Rows per page 30
Slide function
7,981-8,010 of 11,828
16
The slide presents three line charts (A, B, C) comparing PBS, IMI (Imipenem), and two doses of EBO (EBO25, EBO50) over 4 weeks.AN2 Therapeutics | Investor Presentation Deck | 36 slides · AN2 Therapeutics
Pitch deck Investor relations 1 hit
20
The chart shows Log10 CFU counts in lungs for various treatment groups compared to untreated control.AN2 Therapeutics | Investor Presentation Deck | 36 slides · AN2 Therapeutics
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
27
The chart demonstrates superior efficacy of the lead compound over existing treatments (Benznidazole and E1224) in a model that mirrors human clinical outcomes.AN2 Therapeutics | Investor Presentation Deck | 36 slides · AN2 Therapeutics
Pitch deck Investor relations 1 hit
04
The slide uses a grid layout to present four distinct asset categories with corresponding imagery and counts.Creatd | Investor Presentation Deck | 11 slides · Creatd
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
25
The chart shows a clear upward trend in trade volume over the two-year period.Enron | Investor Presentation Deck | 72 slides · Enron
Pitch deck Investor relations 1 hit
26
The chart displays significant volatility in trade volume, with a notable drop-off in early November 2001.Enron | Investor Presentation Deck | 72 slides · Enron
Pitch deck Investor relations 1 hit
27
Includes disclaimer regarding restatement of financials.Enron | Investor Presentation Deck | 72 slides · Enron
Pitch deck Investor relations 1 hit
11
Extended Systems | Investor Presentation Deck | 22 slidesExtended Systems | Investor Presentation Deck | 22 slides · Extended Systems
Pitch deck Investor relations 1 hit
18
The slide uses a custom timeline-like diagram to associate specific acquisitions with product areas.Extended Systems | Investor Presentation Deck | 22 slides · Extended Systems
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
19
The slide uses a dual-metric approach (GM% and $ Millions) to demonstrate financial performance improvement.Extended Systems | Investor Presentation Deck | 22 slides · Extended Systems
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
03
The slide uses a split layout with a financial performance table on the left and a lifestyle image on the right.Hagerty | Investor Presentation Deck | 22 slides · Hagerty
Pitch deck Investor relations Beat · Problem1 hit
04
The slide uses a split-screen layout with a thematic car image on the left and financial highlights on the right.Hagerty | Investor Presentation Deck | 22 slides · Hagerty
Pitch deck Investor relations Beat · Problem1 hit
07
Includes footnotes regarding hurricane impact on loss ratio and non-GAAP measures.Hagerty | Investor Presentation Deck | 22 slides · Hagerty
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
08
The slide uses stacked bar charts to show revenue composition and growth rates for three distinct business segments.Hagerty | Investor Presentation Deck | 22 slides · Hagerty
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
13
The chart highlights a significant projected increase in 2025, likely attributed to the State Farm Classic Plus conversion mentioned in the footnote.Hagerty | Investor Presentation Deck | 22 slides · Hagerty
Pitch deck Investor relations 1 hit
14
The slide uses two charts to demonstrate superior growth (CAGR 15% vs 6%) and superior loss ratios (39% vs 68%).Hagerty | Investor Presentation Deck | 22 slides · Hagerty
Pitch deck Investor relations 1 hit
15
The slide highlights consistent growth in both absolute premium volume and annual percentage growth rates.Hagerty | Investor Presentation Deck | 22 slides · Hagerty
Pitch deck Investor relations 1 hit
07
The slide uses pie charts to illustrate the change in equity stake and valuation.IAC | Investor Presentation Deck | 47 slides · USA Interactive
Pitch deck Investor relations 1 hit
09
The slide illustrates the strategic shift in asset allocation, highlighting the increase in the Expedia stake (represented by the logo) as a percentage of the total portfolio.IAC | Investor Presentation Deck | 47 slides · USA Interactive
Pitch deck Investor relations 1 hit
10
The slide uses pie charts to illustrate the shift in asset allocation towards travel.IAC | Investor Presentation Deck | 47 slides · USA Interactive
Pitch deck Investor relations 1 hit
11
The slide highlights significant improvements in cash position, revenue, and free cash flow over the three-year period.IAC | Investor Presentation Deck | 47 slides · USA Interactive
Pitch deck Investor relations 1 hit
16
The chart highlights USA Interactive in blue to distinguish it from the top 9 competitors.IAC | Investor Presentation Deck | 47 slides · USA Interactive
Pitch deck Investor relations 1 hit
18
The slide presents two distinct groups of metrics separated by a horizontal line, likely distinguishing between user-base metrics and operational/transactional volume.IAC | Investor Presentation Deck | 47 slides · USA Interactive
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
22
The chart shows two distinct growth periods for USA Interactive with CAGR values of 67% and 25%.IAC | Investor Presentation Deck | 47 slides · USA Interactive
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
27
The chart uses stacked bars to indicate an 'Interval' in the 2003 data, likely representing projected vs actual or a specific accounting adjustment.IAC | Investor Presentation Deck | 47 slides · USA Interactive
Pitch deck Investor relations Beat · Financials1 hit
04
The slide highlights clinical and commercial milestones for a CAR-T therapy.Legend Biotech | Investor Presentation Deck | 26 slides · Legend Biotech
Pitch deck Investor relations Loop · Golden Circle1 hit
07
Includes Kaplan-Meier survival curve data.Legend Biotech | Investor Presentation Deck | 26 slides · Legend Biotech
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
09
The chart highlights Carvykti's superior growth curve compared to Kymriah, Yescarta, Tecartus, Breyanzi, and Abecma.Legend Biotech | Investor Presentation Deck | 26 slides · Legend Biotech
Pitch deck Investor relations Loop · Golden Circle1 hit
10
The chart uses a stacked bar format to distinguish between U.S. and OUS (Outside U.S.) sales.Legend Biotech | Investor Presentation Deck | 26 slides · Legend Biotech
Pitch deck Investor relations Loop · Golden Circle1 hit
16
The slide uses a timeline to establish market leadership and a list of competitive moats.Legend Biotech | Investor Presentation Deck | 26 slides · Legend Biotech
Pitch deck Investor relations Beat · CompetitionLoop · Golden Circle1 hit